Deepthi Ramesh, PhD, MSc

Title(s)Postdoctoral Scholar, Pharmaceutical Chemistry
SchoolSchool of Pharmacy
Address555 Mission Bay Blvd South
San Francisco CA 94158
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0002-0493-3700 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Pondicherry University, IndiaPhDMedicinal chemistry

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin-mediated vesicular trafficking pathway. Arch Pharm (Weinheim). 2024 Jun; 357(6):e2300670. Thottasseri AA, Kaur G, Ramesh D, Banerjee I, Kannan T. PMID: 38487979.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Enhancing antifungal properties of chitosan by attaching isatin-piperazine-sulfonyl-acetamide pendant groups via novel imidamide linkage. Int J Biol Macromol. 2023 Jul 31; 244:125428. Gowrivel Vijayakumar B, Ramesh D, Kumari S, Maity A, Pinnaka AK, Kannan T. PMID: 37330090.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    3. Uracil derivatives as HIV-1 capsid protein inhibitors: design, in silico, in vitro and cytotoxicity studies. RSC Adv. 2022 Jun 07; 12(27):17466-17480. Ramesh D, Mohanty AK, De A, Vijayakumar BG, Sethumadhavan A, Muthuvel SK, Mani M, Kannan T. PMID: 35765450; PMCID: PMC9190787.
      View in: PubMed   Mentions: 2  
    4. Chitosan with pendant (E)-5-((4-acetylphenyl)diazenyl)-6-aminouracil groups as synergetic antimicrobial agents. J Mater Chem B. 2022 06 01; 10(21):4048-4058. Vijayakumar BG, Ramesh D, Santhosh Manikandan K, Theresa M, Sethumadhavan A, Priyadarisini VB, Radhakrishnan EK, Mani M, Kannan T. PMID: 35507973.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    5. Acetylene containing 2-(2-hydrazinyl)thiazole derivatives: design, synthesis, and in vitro and in silico evaluation of antimycobacterial activity against Mycobacterium tuberculosis. RSC Adv. 2022 Mar 15; 12(14):8771-8782. Maganti LHB, Ramesh D, Vijayakumar BG, Khan MIK, Dhayalan A, Kamalraja J, Kannan T. PMID: 35424819; PMCID: PMC8984819.
      View in: PubMed   Mentions: 2  
    6. Erratum: First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Arch Pharm (Weinheim). 2022 Apr; 355(4):e2270007. Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, Vijayakumar BG, Chatterjee M, Sriram D, Muthuvel SK, Kannan T. PMID: 35229349.
      View in: PubMed   Mentions:    Fields:    
    7. First-in-class pyrido[2,3-d]pyrimidine-2,4(1H,3H)-diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights. Arch Pharm (Weinheim). 2022 Apr; 355(4):e2100440. Ramesh D, Sarkar D, Joji A, Singh M, Mohanty AK, G Vijayakumar B, Chatterjee M, Sriram D, Muthuvel SK, Kannan T. PMID: 35106845.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    8. Frontiers in Clinical Drug Research: Anti-Infectives. Therapeutic Targets for Emerging Zika Virus Infection and Vaccines in Clinical Trials. 2021; 8(8):260-299. Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan. View Publication.
    9. Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections. ChemMedChem. 2021 05 06; 16(9):1403-1419. Ramesh D, Vijayakumar BG, Kannan T. PMID: 33427377.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    10. Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders. Eur J Med Chem. 2020 Dec 01; 207:112801. Ramesh D, Vijayakumar BG, Kannan T. PMID: 32927231.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    11. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol. 2020 Nov 05; 886:173448. Vijayakumar BG, Ramesh D, Joji A, Jayachandra Prakasan J, Kannan T. PMID: 32768503; PMCID: PMC7406432.
      View in: PubMed   Mentions: 52     Fields:    Translation:Cells
    12. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis. Eur J Med Chem. 2020 Jul 15; 198:112358. Ramesh D, Joji A, Vijayakumar BG, Sethumadhavan A, Mani M, Kannan T. PMID: 32361610.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    Deepthi's Networks
    Concepts (62)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.